For millions of Americans living with attention-deficit hyperactivity disorder (ADHD), a daily prescription can make a profound difference.
Drugs such as Adderall and Ritalin can improve concentration, reduce impulsive behavior and make routine tasks that once felt unmanageable easier to handle.
Because ADHD frequently begins in childhood and continues into adulthood, many people take these medications for years—sometimes decades. But could the medicines that help them function also be placing their hearts under additional strain?
That concern has been raised by research indicating that prolonged use of stimulant medications for ADHD may be associated with a greater risk of cardiovascular disease.
Stimulants account for roughly 90 percent of ADHD prescriptions in the United States. They work by increasing activity in brain chemicals involved in attention and impulse control.
The drugs can also raise heart rate and blood pressure, prompting concern about the possible effects of sustained treatment over many years.
In one major study, people prescribed ADHD medication for more than five years had a 23 percent higher risk of cardiovascular disease and an 80 percent higher risk of developing high blood pressure than people who had not taken the drugs.
The link was especially evident among people taking methylphenidate products, including Ritalin and Concerta, and lisdexamfetamine, sold under the brand name Vyvanse.
Zachary Miron, 15, from Quebec, Canada, died suddenly in January 2024 after drinking an energy drink while taking ADHD medication
London musician Jacob Wooderson, 28, died of heart failure days after his ADHD medication dose was increased
The research does not establish that ADHD medications directly cause heart disease, but it raises important questions for the millions of people who depend on them.
One of those people was 15-year-old Zachary Miron of Quebec, Canada, who died suddenly in January 2024 after consuming an energy drink while taking ADHD medication.
Miron collapsed during a ski trip and died from cardiac arrhythmia, a condition in which the heart beats abnormally fast, slowly or irregularly.
According to the coroner’s report, Miron was taking the ADHD stimulant methylphenidate. It concluded that the combination of caffeine and the medication caused his death. His parents say they had not been warned about the potential risk.
In another case, 28-year-old London musician Jacob Wooderson died of heart failure only days after his ADHD medication dose was increased.
Wooderson collapsed at home in August 2024, six months after being diagnosed. He was initially prescribed 30mg of Elvanse, known as Vyvanse in the US, and his dose was later increased twice.
He told friends and relatives that the higher dose left him feeling unwell and exhausted. Just over two weeks later, he died from sudden arrhythmic death syndrome, which the coroner attributed to the drug.
Although Wooderson had taken the medication for only a short period, researchers are continuing to investigate the relationship between these drugs and cardiovascular health.
So how concerned should patients be—and what steps can they take to protect their hearts without stopping a treatment that may have transformed their lives?
Understanding how these medicines work helps explain why the potential risks are being examined.
ADHD affects the brain’s regulation of attention, motivation and impulse control. People with the condition may find it difficult to focus on routine activities, become easily distracted or experience intense concentration on tasks they find particularly engaging.
These challenges are partly associated with differences in communication between brain regions, including the prefrontal cortex, which plays a role in planning, attention and decision-making.
Two chemical messengers, dopamine and norepinephrine, are central to these processes.
Stimulants such as Adderall and Ritalin increase the activity of these chemicals, helping patients concentrate, control impulses and manage daily responsibilities.
Their effects, however, extend beyond the brain. The same medicines can stimulate the cardiovascular system, increasing both heart rate and blood pressure. That has prompted questions about what may happen when the effects continue for years or even decades.
Dr. Ryan Sultan, a psychiatrist at Columbia University and an ADHD specialist, explained: ‘These medications stimulate the body’s fight-or-flight system.
‘That system prepares the body to respond to danger. It increases alertness, heart rate and blood pressure.
‘Using that response can help people with ADHD become more alert and focused.’
Although this stimulation may improve concentration, it can also increase demands on the cardiovascular system. Experts are paying closer attention to the possible consequences when those effects persist over long periods.
One of the largest studies of the issue, published in JAMA Psychiatry in 2023, analyzed medical records from more than 278,000 people with ADHD in Sweden.
Compared with people who had not taken ADHD medication, those who used it for more than five years had 80 percent higher odds of developing high blood pressure and 23 percent higher odds of cardiovascular disease overall.
The potential risk appeared to become detectable relatively early in treatment.
Those taking ADHD medication for one to two years had nine percent higher odds of cardiovascular disease than nonusers. The figure rose to 15 percent after two to three years and 27 percent after three to five years.
Overall, the researchers estimated that each additional year of medication use was linked to an approximately four percent increase in the odds of cardiovascular disease, with the largest rises occurring during the early years of treatment.
The strongest association involved two widely prescribed stimulants: methylphenidate, marketed under names including Ritalin and Concerta, and lisdexamfetamine, sold as Vyvanse.
In a statement to Our News Outlet, Takeda, the pharmaceutical company that makes Vyvanse, said: ‘Patient safety is our top priority, and we believe it is important for patients to take our medicines according to the FDA-approved label and in consultation with their prescribing health care provider.
‘Complete prescribing and safety information for Vyvanse® (lisdexamfetamine dimesylate), including details about cardiovascular safety considerations, is available in its FDA-approved label.
‘As with any medication, decisions about individual patient management, including assessments of the risks and benefits of available treatments, must be made by the treating health care provider.’
The study did not suggest that every ADHD medication carried the same level of risk. It also could not establish whether one drug was inherently more dangerous than another or prove that the medications directly caused heart disease.
In 2006, the US Food and Drug Administration (FDA) reviewed adverse-event reports from 1999 to 2003. The analysis identified 25 deaths, including 19 children, and 54 serious cardiovascular events—including heart attacks, strokes and arrhythmias—associated with ADHD stimulants.
The review found that several children who died had experienced sudden cardiac arrest and were later diagnosed with previously undetected congenital heart defects. Some adult cases involved preexisting high blood pressure.
One possible explanation involves norepinephrine, a chemical messenger that supports attention but also helps regulate blood pressure.
By increasing norepinephrine activity, stimulants may make the heart beat faster and cause blood vessels to narrow, pushing blood pressure higher.
Persistently elevated blood pressure can damage the arteries over time, increasing the likelihood of heart attacks and strokes.
‘That damage to the blood vessels is likely one factor driving the increased risk of cardiovascular events,’ Sultan said.
However, he emphasized that the findings do not prove the medication is responsible. Studies also indicate that people with ADHD may have a higher underlying risk of cardiovascular disease, whether or not they take medication.
A 2022 Swedish study of more than five million adults found that 38 percent of people with ADHD developed cardiovascular disease over nearly 12 years, compared with 24 percent of those without ADHD.
That association persisted after researchers accounted for ADHD medication use, suggesting that the drugs cannot by themselves explain the difference.
Sultan said people with psychiatric conditions, including ADHD, often have additional heart-disease risk factors, such as increased stress. These overlapping factors make it difficult to determine exactly how much of the elevated risk is linked to medication.
He also cautioned that leaving ADHD untreated can bring serious consequences of its own.
‘Untreated ADHD is not a good thing—it increases the risk of depression, anxiety, substance use, car accidents and overall mortality,’ he said.
‘We prescribe these medications because they have a proven benefit: They help people function in everyday life.’
What, then, should people taking ADHD medication do to safeguard their heart health?
Sultan said patients with existing cardiovascular risk factors—particularly high blood pressure and diabetes—should be especially careful. Cardiovascular risk also tends to rise with age.
‘Adults taking ADHD medication should pay especially close attention to their cardiovascular risk factors, with blood pressure being one of the most important,’ he said.
Routine checks of blood pressure and heart rate can help doctors spot potential problems. Regular exercise, a nutritious diet and avoiding smoking can also lower overall cardiovascular risk.
Physical activity may provide an added benefit for people with ADHD, as research suggests it can improve attention and other symptoms as well.
Sultan called exercise ‘the best thing you can do for your overall health.’
Ultimately, he said, the findings should not prompt people to abandon medication that helps them manage ADHD. Instead, they highlight the need for careful prescribing and ongoing monitoring.
‘The main point is that these medications are not harmless,’ he said.
‘That does not mean you should not take them. It means everyone should approach the decision thoughtfully.’
He also stressed that doctors must be confident a patient genuinely has ADHD before prescribing stimulants.
‘Why take a drug with side effects and a potential increase in cardiovascular risk if you do not actually have the condition?’